BIOSCRIPT HOLDINGS LIMITED

Active Macclesfield

Activities of other holding companies n.e.c.

239 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.
B

BIOSCRIPT HOLDINGS LIMITED

Activities of other holding companies n.e.c.

Founded 16 Feb 2021 Active Macclesfield, England 239 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.

Previous Company Names

LIBRETTO TOPCO LIMITED 16 Feb 2021 — 29 Oct 2021
Accounts Submitted 30 Jun 2025 Next due 30 Jun 2026 2 months remaining
Confirmation Submitted 10 Mar 2026 Next due 2 Mar 2027 10 months remaining
Net assets £-32M £9M 2024 year on year
Total assets £54M £3M 2024 year on year
Total Liabilities £86M £12M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Suite A, Greenway House Larkwood Way Tytherington Business Park Macclesfield SK10 2XR England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for BIOSCRIPT HOLDINGS LIMITED (13203898), an active life sciences and medical technology company based in Macclesfield, England. Incorporated 16 Feb 2021. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2021–2024)

Cash in Bank

£4.75M

Increased by £3.24M (+214%)

Net Assets

-£31.62M

Decreased by £9.26M (-41%)

Total Liabilities

£85.81M

Increased by £12.40M (+17%)

Turnover

£28.07M

Decreased by £26.21k (-0%)

Employees

239

Decreased by 3 (-1%)

Debt Ratio

158%

Increased by 14 (+10%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

11 Allotments 117,098 Shares £19510.06m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
26 Apr 20241,682£900k£535.077
29 Sept 20223,907£37k£9.56
29 Sept 20223,867£115k£29.84
8 Apr 20225,870£16593.74m£2.83m
8 Apr 20222,436£2857.74m£1.17m

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (64)

Sovereign Capital Iv Limited Partnership
52.6%
61,070
Andrew John Medley
14.0%
16,223

Persons with Significant Control

Persons with Significant Control (2)

2 Active
Active
Notified 16 Feb 2021
Nature of Control
  • Significant Influence Or Control

Bb Shelf 4 Llp

United Kingdom

Active
Notified 16 Feb 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

BB SHELF 4 LLP united kingdom
BIOSCRIPT HOLDINGS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Mar 2026Confirmation StatementConfirmation statement made on 2026-02-16 with updates
17 Jul 2025CapitalCapital Return Purchase Own Shares
30 Jun 2025AccountsAnnual accounts made up to 2024-09-30
16 Jun 2025CapitalCapital Return Purchase Own Shares
16 Jun 2025CapitalCapital Cancellation Shares
10 Mar 2026 Confirmation Statement

Confirmation statement made on 2026-02-16 with updates

17 Jul 2025 Capital

Capital Return Purchase Own Shares

30 Jun 2025 Accounts

Annual accounts made up to 2024-09-30

16 Jun 2025 Capital

Capital Return Purchase Own Shares

16 Jun 2025 Capital

Capital Cancellation Shares

Recent Activity

Latest Activity

Confirmation statement made on 2026-02-16 with updates

1 months ago on 10 Mar 2026

Capital Return Purchase Own Shares

9 months ago on 17 Jul 2025

Annual accounts made up to 2024-09-30

9 months ago on 30 Jun 2025

Capital Return Purchase Own Shares

10 months ago on 16 Jun 2025

Capital Cancellation Shares

10 months ago on 16 Jun 2025